Page last updated: 2024-12-05

glycofurol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID110717
SCHEMBL ID166926
MeSH IDM0070225
PubMed CID8200
CHEMBL ID1235254
CHEBI ID44920
SCHEMBL ID15101
MeSH IDM0070225

Synonyms (104)

Synonym
BB 0260585
glycofurol
thfp
5831-59-4
2-((tetrahydrofurfuryl)oxy)ethanol
2-(oxolan-2-ylmethoxy)ethanol
31692-85-0
121182-07-8
einecs 227-407-8
2-(tetrahydro-2-furanylmethoxy)-1-ethanol
AKOS011042244
2-[(tetrahydrofurfuryl)oxy]ethanol
SCHEMBL166926
FT-0699537
2-[(oxolan-2-yl)methoxy]ethan-1-ol
DTXSID40923709
BCP26128
CTPDSKVQLSDPLC-UHFFFAOYSA-N
2-((tetrahydrofuran-2-yl)methoxy)ethanol
CS-0244839
EN300-295427
CHEMBL1235254
tetraglycol
ethanol, 2,2'-[oxybis(2,1-ethanediyloxy)]bis-
nsc-1262
hi-dry
3,9-trioxaundecane-1,11-diol
ethanol,2'-[oxybis(2,1-ethanediyloxy)]bis-
tetraethylene glycol
wln: q2o2o2o2q
112-60-7
nsc1262
carbitol, diethyl
ethanol,2'-[oxybis(ethyleneoxy)]di-
tetraethylene glycol, 99%
2-(2-[2-(2-hydroxyethoxy)ethoxy]ethoxy)ethanol
3,6,9-trioxaundecane-1,11-diol
2,2'-[oxybis(2,1-ethanediyloxy)]bisethanol
NCGC00164038-01
CHEBI:44920 ,
peg-4
2,2'-[oxybis(2,1-ethanediyloxy)]diethanol
3,6,9-trioxaundecan-1,11-diol
2,2'-[oxybis(ethane-2,1-diyloxy)]diethanol
brn 1634320
nsc 1262
einecs 203-989-9
hsdb 843
ai3-01838
ethanol, 2,2'-(oxybis(2,1-ethanediyloxy))bis-
ethanol, 2,2'-(oxybis(ethyleneoxy))di-
2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethanol
T0099
AKOS000119933
NCGC00164038-02
9004-76-6
unii-r95b8j264j
r95b8j264j ,
ec 203-989-9
cas-112-60-7
dtxcid806922
NCGC00257035-01
tox21_303245
dtxsid9026922 ,
NCGC00259178-01
tox21_201629
125481-05-2
127821-00-5
FT-0689175
BP-20324
FT-0645137
2-{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}ethan-1-ol
2,2'-((oxybis(ethane-2,1-diyl))bis(oxy))diethanol
c8h18o5
STL268854
tetraethylenglycol
tetra-ethylene glycol
tetra(ethylene glycol)
tetraethyleneglycol
2-{2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethoxy}-ethanol
2-(2-(2-(2-hydroxy-ethoxy)ethoxy)ethoxy)ethanol
bis[2-(2-hydroxyethoxy)ethyl] ether
SCHEMBL15101
1,11-dihydroxy-3,6,9-trioxaundecane
2,2'-(oxybis(ethyleneoxy))diethanol
protac linker 18
F8889-3081
mfcd00002879
J-519899
ho-peg4-oh
W18472
2,2'-((oxybis(ethane-2,1-diyl))bis(oxy))bis(ethan-1-ol)
2-{2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethoxy}-
2,2'-(2,2'-oxybis(ethane-2,1-diyl)bis(oxy))diethanol
prednisolonetebutate(200mg)
FT-0763791
DS-17878
157299-02-0
Q12430182
oh-peg4-oh
HY-W018745
CS-W019531
SY010865
EN300-19499

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Pharmacokinetic studies indicated that glycofurol inhibited CBZ metabolism by decreasing formation of the major CBZ metabolite CBZ-10,11-epoxide (CBZ-E)."( New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin: tolerability and pharmacokinetics after intravenous injection in comparison to a glycofurol-based formulation.
Brewster, ME; Düsing, R; Hönack, D; Löscher, W; Richter, A; Schulz, HU; Schürer, M, 1995
)
0.29
" Elimination half-life was significantly lower in the SEDDM Tac group."( Pharmacokinetics of a self-microemulsifying drug delivery system of tacrolimus.
Gruber, M; Hirt, SW; Kunz, W; Lehle, K; Schmid, C; Touraud, D; von Suesskind-Schwendi, M, 2013
)
0.39

Bioavailability

ExcerptReferenceRelevance
"The aim of the present study was to investigate the absolute nasal bioavailability of Peptide T from aqueous formulations containing sodium glycocholate, an absorption enhancer with known effect on epithelial tight junctions, and/or glycofurol in a crossover study in rabbits."( Nasal bioavailability of peptide T in rabbits: absorption enhancement by sodium glycocholate and glycofurol.
Bagger, MA; Bechgaard, E; Nielsen, HW, 2001
)
0.31
" The results of the pharmacokinetic study indicate that the SMEDDS formulation shows significantly greater bioavailability than the raw sirolimus powder or commercial product (Rapamune® oral solution)."( Optimized formulation of solid self-microemulsifying sirolimus delivery systems.
Cha, KH; Cho, W; Hwang, SJ; Kim, JS; Kim, MS; Park, HJ; Park, J; Park, JS, 2013
)
0.39
"In order to characterize the in situ intestinal permeability and in vivo oral bioavailability of celecoxib (CXB), a poorly water-soluble cyclooxygenase (COX)-2 inhibitor, various formulations including the self-emulsifying drug delivery system (SEDDS) and supersaturating SEDDS (S-SEDDS) were compared."( In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system.
Chae, BR; Choi, YW; Lee, DH; Lee, KM; Song, SH; Song, WH; Yeom, DW; Yoo, HJ, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
"The present work consists of studies of saturated and supersaturated solutions of diazepam (DZP) in [glycofurol (GF)/water] cosolvent systems, which are a potential dosage form for intranasal administration of DZP in rapid response to epileptic seizure emergencies."( Enhanced permeation of diazepam through artificial membranes from supersaturated solutions.
Hou, H; Siegel, RA, 2006
)
0.33
" The selection of the optimum SMEDDS Tac composition might have advantage as an alternative oral dosage form for Tac."( Pharmacokinetics of a self-microemulsifying drug delivery system of tacrolimus.
Gruber, M; Hirt, SW; Kunz, W; Lehle, K; Schmid, C; Touraud, D; von Suesskind-Schwendi, M, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (3 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care2
Household Essentials1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Hempz Scalp Care Herbal Conditioner Tea Tree & Chamomile -- 17 fl ozHempzBeauty & Personal Careaminomethyl propanol, iodopropynyl butylcarbamate, citric acid, acetic acid, cetearyl alcohol, cetyl alcohol, chlorphenesin, citric acid, tocopherol, panthenol, disodium EDTA, etidronic acid, tocopherol, glycerin, PEG-4, dimethicone, hydroxyethylcellulose, menthol, octyldodecanol, phenoxyethanol, laureth-9, sodium acetate, stearyl alcohol2024-11-29 10:47:42
Hempz Triple Moisture Herbal Conditioner Fresh Citrus -- 17 fl ozHempzBeauty & Personal Careiodopropynyl butylcarbamate, citric acid, acetic acid, benzyl benzoate, cetearyl alcohol, cetyl alcohol, chlorphenesin, citric acid, tocopherol, panthenol, disodium EDTA, etidronic acid, tocopherol, glycerin, PEG-4, dimethicone, hydroxyethylcellulose, limonene, linalool, octyldodecanol, phenoxyethanol, sodium acetate, sodium benzoate, stearyl alcohol2024-11-29 10:47:42
If You Care Automatic Dishwasher Tablets Free & Clear -- 40 TabletsIf You CareHousehold EssentialsPEG-4, sodium citrate, sodium carbonate peroxide, sorbitol2024-11-29 10:47:42

Drug Classes (1)

ClassDescription
poly(ethylene glycol)A polymer composed of repeating ethyleneoxy units.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency33.29380.003041.611522,387.1992AID1159552; AID1159555
farnesoid X nuclear receptorHomo sapiens (human)Potency0.19490.375827.485161.6524AID743220
pregnane X nuclear receptorHomo sapiens (human)Potency39.81070.005428.02631,258.9301AID720659
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency0.10860.001019.414170.9645AID743094; AID743140
activating transcription factor 6Homo sapiens (human)Potency1.25620.143427.612159.8106AID1159516
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency12.58930.010039.53711,122.0200AID588547
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency15.35530.000627.21521,122.0200AID720636
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (9.26)18.7374
1990's5 (9.26)18.2507
2000's14 (25.93)29.6817
2010's25 (46.30)24.3611
2020's5 (9.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.17 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index51.24 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.38%)5.53%
Trials0 (0.00%)5.53%
Reviews2 (4.76%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other39 (92.86%)84.16%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]